Fr. 71.00

AMIDIN: Synthesis and investigation of its anti-diabetic properties - Synthesized from N-Ethyl-N'-(4H-1,2,4-triazol-3-yl)ethanamidine

English · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

In the present study, we synthesized N-Ethyl-N'-(4H-1,2,4-triazol-3-yl) ethanamidine. We subsequently tried to test the action of amidine 2 at different doses ranging from 0.1mg to 0.4mg/kg bw on glucose-induced hyperglycemia in mice by comparing this effect with that of MetF a standard molecule. Starch significantly reduced blood glucose levels in normal and subacute hyperglycemic mice by glucose administration. In this context, we showed an increase in lipid peroxidation and a decrease in thiol groups.These alterations are accompanied by a reduction in antioxidant power. This protective action of the tested molecule would be essentially linked to its antioxidant activity and its action of improvement of the antioxidant enzymes. Starch induced a significant decrease of the concentration of glucose in blood and protected against the loss of body weight after a duration of treatment 30 days in mice made diabetic by alloxane, a very important diabetogenic chemical product

About the author










Dr. Azhar HAJRIDoutor em química orgânica (química dos heterócitos).Professor assistente na ISB Béja, Universidade de Jendouba, Tunísia

Product details

Authors Azhar HAJRI
Publisher Our Knowledge Publishing
 
Languages English
Product format Paperback / Softback
Released 17.10.2022
 
EAN 9786205256800
ISBN 9786205256800
No. of pages 84
Subject Natural sciences, medicine, IT, technology > Chemistry > Organic chemistry

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.